Back to search

Article

Management of Refractory Malignancy-Associated Hemophagocytic Lymphohistiocytosis in Pediatric Patients: A Case Series of Novel Therapeutics and Treatment Challenges

2025-01-04

Abstract excerpt

Hemophagocytic lymphohistiocytosis (HLH) is a potentially fatal syndrome of immune dysregulation that has primary and secondary forms. HLH is classified based on underlying triggers of malignancy, infections, and/or autoimmune processes. Primary-HLH has a genetic etiology related to defects in cytotoxic T and NK cells. The established standard of care is dexamethasone and etoposide but no guidelines exist for refr...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
dd7d51ac-0d00-5943-a86b-d3a27fde8215
DOI
10.22541/au.173599410.06496449/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Management of Refractory Malignancy-Associated Hemophagocytic Lymphohistiocytosis in Pediatric Patients: A Case Series of Novel Therapeutics and Treatment ChallengesDOI 10.22541/au.173599410.06496449/v1
Select a neighboring publication to make it the new centre.